FDG-PET/CT–based restaging may alter initial management decisions and clinical outcomes in patients with locally advanced pancreatic carcinoma planned to undergo chemoradiotherapy

The impact of [(18)F]fluorodeoxyglucose-positron emission tomography (PET)/computed tomography (CT) restaging on management decisions and outcomes in patients with locally advanced pancreatic carcinoma (LAPC) scheduled for concurrent chemoradiotherapy (CRT) is examined. Seventy-one consecutive patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Topkan, Erkan, Parlak, Cem, Yapar, Ali Fuat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: e-Med 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830425/
https://www.ncbi.nlm.nih.gov/pubmed/24240137
http://dx.doi.org/10.1102/1470-7330.2013.0035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830425/
https://www.ncbi.nlm.nih.gov/pubmed/24240137
http://dx.doi.org/10.1102/1470-7330.2013.0035

Ejemplares similares